Epidemiological and antimicrobial resistance characteristics of recent (2021–2024) Chinese Actinobacillus pleuropneumoniae clinical isolates

Abstract

Actinobacillus pleuropneumoniae is the causative agent of porcine contagious pleuropneumonia, which causes significant economic losses to the global swine industry. To determine the current epidemiological trends and antimicrobial resistance profiles of A. pleuropneumoniae in China, we analyzed 90 clinical isolates collected from 20 provinces between 2021 and 2024. Serotyping indicated that serovar 15 has emerged as the predominant type (accounting for 36.7% of isolates), with its prevalence increasing markedly since 2021 and reaching 52.6% in 2024. In contrast, the prevalence of previously common serovars 1 and 7 fluctuated or decreased. The isolates demonstrated high resistance rates to doxycycline hydrochloride (77.8%) and florfenicol (47.8%). Notably, the proportion of multidrug-resistant (MDR) isolates increased substantially from 0% in 2021 to 42.1% in 2024, with MDR phenotypes being particularly prevalent among serovars 15 and 7. Correlation analysis revealed a significant risk of cross-resistance among certain antibiotics, including cephalosporins. Biological characteristics, including growth rate and hemolytic activity, differ among serovars. This study highlights significant shifts in the predominant serovars and resistance patterns of A. pleuropneumoniae in China, underscoring the need for continuous pathogen surveillance to guide vaccine development and the rational use of antibiotics.

Keywords

Actinobacillus pleuropneumoniae / Serotyping / Antimicrobial resistance / Biological characteristics

References

[1] Aper D, Frömbling J, Bağcıoğlu M, Ehling-Schulz M, Hennig-Pauka I. Comparison of metabolic adaptation and biofilm formation of Actinobacillus pleuropneumoniae field isolates from the upper and lower respiratory tract of swine with respiratory disease. Veterinary Microbiology, 2020, 240 108532

[2] Arnal Bernal JL, Gottschalk M, Lacotoure S, Sanz Tejero C, Chacón Pérez G, Martín-Jurado D, Fernández Ros AB. Serotype diversity of Actinobacillus pleuropneumoniae detected by real-time PCR in clinical and subclinical samples from Spanish pig farms during 2017-2022. Veterinary Research, 2024, 55(1 165

[3] Beck M, van den Bosch JF, Jongenelen IM, Loeffen PL, Nielsen R, Nicolet J, Frey J. RTX toxin genotypes and phenotypes in Actinobacillus pleuropneumoniae field strains. Journal of Clinical Microbiology, 1994, 32(11): 2749-2754

[4] Boekema BK, Kamp EM, Smits MA, Smith HE, Stockhofe-Zurwieden N. Both ApxI and ApxII of Actinobacillus pleuropneumoniae serotype 1 are necessary for full virulence. Veterinary Microbiology, 2004, 100(1-2): 17-23

[5] Bossé JT, Janson H, Sheehan BJ, Beddek AJ, Rycroft AN, Kroll JS, Langford PR. Actinobacillus pleuropneumoniae: Pathobiology and pathogenesis of infection. Microbes and Infection, 2002, 4(2): 225-235

[6] Bossé JT, Li Y, Atherton TG, Walker S, Williamson SM, Rogers J, Chaudhuri RR, Weinert LA, Holden MT, Maskell DJ, et al.. Characterization of a mobilisable plasmid conferring florfenicol and chloramphenicol resistance in Actinobacillus pleuropneumoniae. Veterinary Microbiology, 2015, 178(3-4): 279-282

[7] Bossé JT, Li Y, Sárközi R, Fodor L, Lacouture S, Gottschalk M, Casas Amoribieta M, Angen Ø, Nedbalcova K, Holden MTG, et al.. Proposal of serovars 17 and 18 of Actinobacillus pleuropneumoniae based on serological and genotypic analysis. Veterinary Microbiology, 2018, 217: 1-6

[8] Brenciani A, Coccitto SN, Cucco L, Ustulin M, Albini E, Paniccià M, Vio D, Cinthi M, Giovanetti E, Massacci FR, et al.. Emerging resistance to florfenicol in Actinobacillus pleuropneumoniae isolates on two Italian pig farms. Veterinary Microbiology, 2024, 296 110186

[9] Chien MS, Chan YY, Chen ZW, Wu CM, Liao JW, Chen TH, Lee WC, Yeh KS, Hsuan SL. Actinobacillus pleuropneumoniae serotype 10 derived ApxI induces apoptosis in porcine alveolar macrophages. Veterinary Microbiology, 2009, 135(3-4): 327-333

[10] Chiers K, De Waele T, Pasmans F, Ducatelle R, Haesebrouck F. Virulence factors of Actinobacillus pleuropneumoniae involved in colonization, persistence and induction of lesions in its porcine host. Veterinary Research, 2010, 41(5 65

[11] CLSI. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals, 2024, Wayne, PA, Clinical and Laboratory Standards Institute

[12] Cohen LM, Bossé JT, Stegger M, Li Y, Langford PR, Kielland C, Klem TB, Gulliksen SM, Ranheim B, Grøntvedt CA, et al.. Comparative genome sequence analysis of Actinobacillus pleuropneumoniae serovar 8 isolates from Norway, Denmark, and the United Kingdom indicates distinct phylogenetic lineages and differences in distribution of antimicrobial resistance genes. Frontiers in Microbiology, 2021, 12 729637

[13] de Almeida MN, Pineyro PP, Holtkamp D, Machado I, Silva APS, Cezar G, Thomas P, Gottschalk M, Michael AA. Postoutbreak dynamics and persistence of Actinobacillus pleuropneumoniae serotype 15 in finisher pigs in Iowa. Veterinary Research, 2025, 56(1 107

[14] Dom P, Haesebrouck F. Comparative virulence of NAD-dependent and NAD-independent Actinobacillus pleuropneumoniae strains. Zentralblatt Für Veterinärmedizin. Reihe B, 1992, 39(4): 303-306

[15] Dom P, Haesebrouck F, Kamp EM, Smits MA. NAD-independent Actinobacillus pleuropneumoniae strains: Production of RTX toxins and interactions with porcine phagocytes. Veterinary Microbiology, 1994, 39(3-4): 205-218

[16] El Garch F, de Jong A, Simjee S, Moyaert H, Klein U, Ludwig C, Marion H, Haag-Diergarten S, Richard-Mazet A, Thomas V, et al.. Monitoring of antimicrobial susceptibility of respiratory tract pathogens isolated from diseased cattle and pigs across Europe, 2009-2012: VetPath results. Veterinary Microbiology, 2016, 194: 11-22

[17] Frey J. Virulence in Actinobacillus pleuropneumoniae and RTX toxins. Trends in Microbiology, 1995, 3(7): 257-261

[18] Gottschalk M. The challenge of detecting herds subclinically infected with Actinobacillus pleuropneumoniae. The Veterinary Journal, 2015, 206(1): 30-38

[19] Guarneri F, Romeo C, Scali F, Zoppi S, Formenti N, Maisano AM, Catania S, Gottschalk M, Alborali GL. Serotype diversity and antimicrobial susceptibility profiles of Actinobacillus pleuropneumoniae isolated in Italian pig farms from 2015 to 2022. Veterinary Research, 2024, 55(1 48

[20] Güssow D, Clackson T. Direct clone characterization from plaques and colonies by the polymerase chain reaction. Nucleic Acids Research, 1989, 17(10 4000

[21] Hennig-Pauka I, Hartmann M, Merkel J, Kreienbrock L. Coinfections and phenotypic antimicrobial resistance in Actinobacillus pleuropneumoniae strains isolated from diseased swine in north western Germany-temporal patterns in samples from routine laboratory practice from 2006 to 2020. Frontiers in Veterinary Science, 2021, 8 802570

[22] Holmer I, Salomonsen CM, Jorsal SE, Astrup LB, Jensen VF, Høg BB, Pedersen K. Antibiotic resistance in porcine pathogenic bacteria and relation to antibiotic usage. BMC Veterinary Research, 2019, 15(1 449

[23] Holmgren N, Lundeheim N, Wallgren P. Infections with Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae in fattening pigs. Influence of piglet production systems and influence on production parameters. Zentralblatt Für Veterinärmedizin. Reihe B, 1999, 46(8): 535-544

[24] Jacobsen MJ, Nielsen JP, Nielsen R. Comparison of virulence of different Actinobacillus pleuropneumoniae serotypes and biotypes using an aerosol infection model. Veterinary Microbiology, 1996, 49(3-4): 159-168

[25] Jacques M, Aragon V, Tremblay YD. Biofilm formation in bacterial pathogens of veterinary importance. Animal Health Research Reviews, 2010, 11(2): 97-121

[26] Kim B, Hur J, Lee JY, Choi Y, Lee JH. Molecular serotyping and antimicrobial resistance profiles of Actinobacillus pleuropneumoniae isolated from pigs in South Korea. Veterinary Quarterly, 2016, 36(3): 137-144

[27] Li F, Zong X, Chen G, Zhang Y, Cao Q, Li L, Chen H, Peng Z, Tan C. Isolation, antimicrobial susceptibility, and genotypes of three Pasteurellaeae species prevalent on pig farms in China between 2021 and 2023. Microorganisms, 2025, 13(4 938

[28] Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al.. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clinical Microbiology and Infection, 2012, 18(3): 268-281

[29] Morioka A, Asai T, Nitta H, Yamamoto K, Ogikubo Y, Takahashi T, Suzuki S. Recent trends in antimicrobial susceptibility and the presence of the tetracycline resistance gene in Actinobacillus pleuropneumoniae isolates in Japan. The Journal of Veterinary Medical Science, 2008, 70(11): 1261-1264

[30] Nahar N, Turni C, Tram G, Blackall PJ, Atack JM. Actinobacillus pleuropneumoniae: The molecular determinants of virulence and pathogenesis. Advances in Microbial Physiology, 2021, 78: 179-216

[31] Nedbalcova K, Nechvatalova K, Pokludova L, Bures J, Kucerova Z, Koutecka L, Hera A. Resistance to selected beta-lactam antibiotics. Veterinary Microbiology, 2014, 171(3-4): 328-336

[32] Ozawa M, Kawano M, Abo H, Issiki Y, Kumakawa M, Kawanishi M, Kojima A, Iwamoto S. Characterization of Actinobacillus pleuropneumoniae isolated from pigs in Japan using whole-genome sequencing. Comparative Immunology, Microbiology & Infectious Diseases, 2023, 102 102062

[33] Paulina P, Dawid T. Serotyping and antimicrobial resistance of Actinobacillus pleuropneumoniae isolates from fattening pigs in Poland from 2019 to 2024. BMC Veterinary Research, 2025, 21(1 40

[34] Sassu EL, Bossé JT, Tobias TJ, Gottschalk M, Langford PR, Hennig-Pauka I. Update on Actinobacillus pleuropneumoniae-knowledge, gaps and challenges. Transboundary and Emerging Diseases, 2018, 65(1): 72-90

[35] Schuwerk L, Hoeltig D, Waldmann KH, Valentin-Weigand P, Rohde J. Sero- and apx-typing of German Actinobacillus pleuropneumoniae field isolates from 2010 to 2019 reveals a predominance of serovar 2 with regular apx-profile. Veterinary Research, 2021, 52(1 10

[36] Schwarz S, Kehrenberg C, Walsh T. Use of antimicrobial agents in veterinary medicine and food animal production. International Journal of Antimicrobial Agents, 2001, 17(6): 431-437

[37] Siteavu MI, Drugea RI, Pitoiu E, Ciobotaru-Pirvu E. Antimicrobial resistance of Actinobacillus pleuropneumoniae, Streptococcus suis, and Pasteurella multocida isolated from Romanian swine farms. Microorganisms, 2023, 11(10 2410

[38] Stringer OW, Bossé JT, Lacouture S, Gottschalk M, Fodor L, Angen Ø, Velazquez E, Penny P, Lei L, Langford PR, et al.. Proposal of Actinobacillus pleuropneumoniae serovar 19, and reformulation of previous multiplex PCRs for capsule-specific typing of all known serovars. Veterinary Microbiology, 2021, 255 109021

[39] Stygar AH, Niemi JK, Oliviero C, Laurila T, Heinonen M. Economic value of mitigating Actinobacillus pleuropneumoniae infections in pig fattening herds. Agricultural Systems, 2016, 144: 113-121

[40] Vanni M, Merenda M, Barigazzi G, Garbarino C, Luppi A, Tognetti R, Intorre L. Antimicrobial resistance of Actinobacillus pleuropneumoniae isolated from swine. Veterinary Microbiology, 2012, 156(1-2): 172-177

[41] Vincent AT, Lacouture S, St-Jean G, Tapia R, Payen S, Kon M, Frey J, To H, Gottschalk M. Atypical Actinobacillus pleuropneumoniae serotype 12 strains with a higher virulence potential. Veterinary Research, 2025, 56(1 149

[42] Xu M, Ke H, Zang Y, Gou H, Yang D, Shi K, Zhang K, Li Y, Jiang Z, Chu P, et al.. Outer membrane vesicles secreted from Actinobacillus pleuropneumoniae isolate disseminating the floR resistance gene to Enterobacteriaceae. Frontiers in Microbiology, 2024, 15 1467847

[43] Yao X, Song Q, Zhu W, Wei J, Shao D, Liu K, Li Z, Qiu Y, Ma Z, Xia L, et al.. Characterization of small plasmids carrying florfenicol resistance gene floR in Actinobacillus pleuropneumoniae and Pasteurella multocida isolates from swine in China. Frontiers in Veterinary Science, 2023, 10 1084491

[44] Zhang Q, Peng L, Han W, Chen H, Tang H, Chen X, Langford PR, Huang Q, Zhou R, Li L. The morphology and metabolic changes of Actinobacillus pleuropneumoniae during its growth as a biofilm. Veterinary Research, 2023, 54(1 42

Funding

National Natural Science Foundation of China(32473032)

RIGHTS & PERMISSIONS

The Author(s)